S1GMA

S1GMA

Danger IndexSupply CalculatorMorse CodeGardenPrep QuizSurvival GameSignal MapArticles
StoreAbout
S1GMA
S1GMA

Survival Intelligence for the Prepared Mind. Real-time threat monitoring, preparedness resources, and community connections.

Intelligence
Signals MapArticlesDanger IndexThe 4+1 Pillars
Tools
Supply CalculatorMorse TranslatorGarden CalendarPrep Quiz
Resources
Survival Kits3D PrintsDIY ProjectsGear Store
Apps & Community
NO REMORSE (Morse)Find Communities
Company
AboutContactPrivacy PolicyTerms of Service

© 2026 S1GMA. All rights reserved.

X / TwitterTikTok
Back to Signals
Drug development targeting the mitochondrial respiratory chain of Sparganum proliferum: Initial biochemical and drug discovery insights into the enigmatic helminth parasite
health_biological
parasitic-infection
drug-development
neglected-tropical-disease

Drug development targeting the mitochondrial respiratory chain of Sparganum proliferum: Initial biochemical and drug discovery insights into the enigmatic helminth parasite

Plos.org

•

Wednesday, August 19, 2026

•

Global

Sparganum proliferum is a rare but devastating parasite. Unlike typical tapeworms, it reproduces uncontrollably in the human body, invading organs like the brain, liver, and skin. With no known cure and a largely mysterious lifecycle, infection represents a severe medical threat. This research article presents initial biochemical and drug discovery insights targeting the parasite's mitochondrial respiratory chain as a potential therapeutic approach.

Sources (1)
Plos.org
Wednesday, August 19, 2026
Drug development targeting the mitochondrial respiratory chain of Sparganum proliferum: Initial biochemical and drug discovery insights into the enigmatic helminth parasiteBy Shigehiro Enkai, Yurie Nakano, Madoka Koyanagi, Yutaka Arimura, Hirotaka Kanuka, Kenji Ishiwata